Last edition
News about " Aesculap AEOS"
New Invivoscribe Platform Targets KMT2A Rearrangements in AML Trials
Invivoscribe, a precision diagnostics company focused on measurable residual disease (MRD) testing, has expanded its oncology portfolio with the launch of the LeukoStrat KMT2A + MRD Assay and Software.
Aesculap AEOS | 06/02/2026 | By Darshana | 150
B Braun Acquires True Digital Surgery
Before the acquisition, B Braun held a minority stake in TDS. The decision to fully acquire TDS allows B Braun's surgical division Aesculap to secure the valuable expertise of the TDS team, ensuring the continuous technological advancement of Aesculap AEOS.
Aesculap AEOS | 13/09/2025 | By Dineshwori | 275
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy